Lonza teams with hospital to produce CAR-T cells at point-of-care

By Maggie Lynch contact

- Last updated on GMT

(Image: Getty/dk_photos)
(Image: Getty/dk_photos)

Related tags: CAR-T, CDMO, Lonza, Middle east, israel, Cell therapy, Cell therapy manufacturing, Personalized medicine

Lonza and Israel-based Sheba Medical collaborate to use the CDMO’s manufacturing platform for point-of-care genetically engineered human CAR-T cell production.

Through the agreement Sheba, the largest hospital in Israel and the Middle East region will be able to bolster its in-house cell manufacturing process to produce human CAR-T cells for applications at point-of-care treatment.

Lonza, a Swiss contract development and manufacturing organization (CDMO), will transfer Sheba’s current open, manual protocols, into Lonza’s closed automated Cocoon platfor

Lonza cassette on cocoon
(Image: Lonza) Cassette on Cocoon

m​.

The Cocoon platform was developed by Lonza in a collaboration with Octane Biotech. It is a good manufacturing process (GMP) concept for autologous cell therapy manufacturing.

Use of the manufacturing platform will provide Sheba with the capability to produce cell therapies in a scalable manner at a lower cost.

A spokesperson for Lonza told us that the Cocoon is currently in beta-testing and is now at a stage where the company is looking to test the system at the point of care.

“The goal is to make the Cocoon available to clinics as well as biotech and pharma companies, enabling them to treat more patients and reduce the costs of goods,”​ the spokesperson added.

Dror Harats, deputy director for research and development, director of Clinical Trials at Sheba Medical Center, said in a statement, “With the collaborative potential of this venture, we look forward to jointly leading the next personalized cell-therapy revolution.”

Related news

Show more

Related products

show more

Keys To A Successful Rapid Commercial Launch

Keys To A Successful Rapid Commercial Launch

Catalent Pharma Solutions | 21-Oct-2020 | Insight Guide

Pharma and biotech companies are dedicating resources to new treatments with the hope of helping patients. The quicker they can get products to patients,...

Innovations in OSD

Innovations in OSD

Recorded the 06-Oct-2020 | Webinar

This DFE series of educational webinars looks at innovations in Oral Solid Dose Forms with the emergence of advanced technologies such as Continuous Manufacturing...

Register for free

Lessons Learned: Clinical Trials During a Pandemic

Lessons Learned: Clinical Trials During a Pandemic

PCM TRIALS | 01-Sep-2020 | Technical / White Paper

In a recent survey of clinical trial professionals (including pharmaceutical sponsors, CROs, site representatives and vendors), respondents reported that...

Related suppliers

Follow us

Products

View more

Webinars